Drug interactions
Insulin neutral human + Rosiglitazone
Severity: Major
Insulin neutral human and Rosiglitazone: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Rosiglitazone with insulin increases the risk of fluid retention, edema, heart failure and hypoglycemia. The combination also carries a labeled cardiovascular concern, particularly in patients with cardiac risk.
What this interaction means in plain words
Insulin neutral human and Rosiglitazone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Insulin neutral human belongs to Endocrine; Rosiglitazone belongs to Endocrine.
Why it happens
Additive improvement in insulin sensitivity plus PPAR-gamma-mediated sodium and fluid retention, which insulin can aggravate.
What to do
Avoid the combination in patients with heart failure or high cardiovascular risk; if used, reduce the insulin dose as needed and monitor weight, edema and cardiac symptoms.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Insulin neutral human and Rosiglitazone, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Insulin neutral human
Other interactions of Rosiglitazone
- Insulin aspart protamine / insulin aspart + Rosiglitazone Major
- Insulin aspart-insulin aspart protamine + Rosiglitazone Major
- Insulin aspart + Rosiglitazone Major
- Insulin degludec / insulin aspart + Rosiglitazone Major
- Insulin degludec-insulin aspart + Rosiglitazone Major
- Insulin degludec-liraglutide + Rosiglitazone Major
Frequently asked questions
Can I take Insulin neutral human with Rosiglitazone?
MediHelp rates the interaction as major. Insulin neutral human and Rosiglitazone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Rosiglitazone with insulin increases the risk of fluid retention, edema, heart failure and hypoglycemia. The combination also carries a labeled cardiovascular concern, particularly in patients with cardiac risk.
How serious is the interaction between Insulin neutral human and Rosiglitazone?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination in patients with heart failure or high cardiovascular risk; if used, reduce the insulin dose as needed and monitor weight, edema and cardiac symptoms.
What other medicines interact with Insulin neutral human?
MediHelp also lists interactions of Insulin neutral human with, for example, Chlorpropamide, Ethanol, Mecasermin. The full list is on the Insulin neutral human page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
